Fact CheckerSign in

NCT06840847Completed

Sexual Coercion in Breast Cancer Patients Treated With Luteinizing Hormone-Releasing Hormone Agonists (LHRHa )

Source: ClinicalTrials.gov · Last updated 25 Feb 2025

Brief summary (registry, in English)

The use of luteinizing hormone-releasing hormone agonists(LHRHa) to suppress ovarian function is a common strategy for treating premenopausal, hormone receptor-positive breast cancer. However, this approach can lead to more severe and prolonged menopausal symptoms, which can further impact intimate relationships and sexual function. Sexual coercion, encompassing both overt and subtle forms of pressure, is a significant global public health concern that threatens individual well-being.

Status (registry)
Completed
Study type
Interventional
Enrollment
79 (actual)
First submitted
1 Feb 2025
Start date
1 Jan 2024
Primary completion date
1 Oct 2024
Lead sponsor
Canan Kas
NCT number
NCT06840847

What you commit to

  • Study type: Interventional
  • Participants enrolled: 79
  • From 1 Jan 2024 to the primary completion date, 1 Oct 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • currently receiving active chemotherapy or less than 3 months since completing chemotherapy
  • receiving treatment for metastatic disease
  • The use of selective serotonin reuptake inhibitors

Other illness

  • having any neuropsychiatric disorder
  • having any mental illness
  • having a history of gynecological surgery

Who the study is looking for

  • being over 18 years of age
  • willingness to participate in this study
  • having received treatment for breast cancer
  • having a history of breast cancer surgery
  • having an active relationship with a spouse or partner.

Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Kastamonu University
Coordinator of this site? Confirm its status
KastamonuTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.